Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Immunogenicity of full-length P. vivax rPvs48/45 protein formulations in BALB/c mice.
Vaccine. 2022 Jan 3;40(1):133-140. doi: 10.1016/j.vaccine.2021.11.036. Epub 2021 Nov 19.
Vaccine. 2022.
PMID: 34802791
Free PMC article.
Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems.
Arévalo-Herrera M, Miura K, Cespedes N, Echeverry C, Solano E, Castellanos A, Ramirez JS, Miranda A, Kajava AV, Long C, Corradin G, Herrera S.
Arévalo-Herrera M, et al.
Front Immunol. 2021 Jun 24;12:634738. doi: 10.3389/fimmu.2021.634738. eCollection 2021.
Front Immunol. 2021.
PMID: 34248932
Free PMC article.
Item in Clipboard
Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with sera from Plasmodium falciparum endemic areas of Africa.
Balam S, Miura K, Ayadi I, Konaté D, Incandela NC, Agnolon V, Guindo MA, Diakité SAS, Olugbile S, Nebie I, Herrera SM, Long C, Kajava AV, Diakité M, Corradin G, Herrera S, Herrera MA.
Balam S, et al.
bioRxiv [Preprint]. 2024 Apr 15:2024.04.10.588966. doi: 10.1101/2024.04.10.588966.
bioRxiv. 2024.
PMID: 38659832
Free PMC article.
Preprint.
Item in Clipboard
Cite
Cite